Aeterna Wealth

Mutual funds holding IPCA Laboratories shares

95 mutual fund schemes held IPCA Laboratories shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹13,288 cr in all. The largest holders by value are HDFC Mid Cap Fund (3.4% of the fund), Kotak Mid Cap Fund (3.6% of the fund), Axis Midcap Fund (2.3% of the fund).

Against the month before, 1 scheme added IPCA Laboratories as a new holding and 0 sold out of it completely.

New holders: Capitalmind Flexi Cap Fund

By category: Index Fund (34), Sectoral/Thematic (21), Mid Cap (14), Large & Mid Cap (6), Flexi Cap (5), Multi Cap (5).

7 actively managed schemes holding it are rated A+ or A on their track record, among them Mirae Asset Healthcare Fund, HDFC Pharma and Healthcare Fund, Nippon India Balanced Advantage Fund, DSP Aggressive Hybrid Fund, quant Healthcare Fund.

Every scheme holding IPCA Laboratories, by value

SchemeRating% of fundValueChange
HDFC Mid Cap FundMid CapC3.43%₹3,453 cr–
Kotak Mid Cap FundMid CapC3.57%₹2,307 cr–
Axis Midcap FundMid CapB2.30%₹769 cr–
Nippon India Growth Mid Cap FundMid CapB1.22%₹597 cr+0.03
DSP Midcap FundMid CapC2.94%₹554 cr+0.10
Kotak Large & Mid Cap FundLarge & Mid CapB1.59%₹480 cr–
DSP Small Cap FundSmall CapB2.27%₹460 cr+0.13
Edelweiss Mid Cap FundMid CapB1.84%₹344 cr–
DSP Healthcare FundSectoral/ThematicB7.49%₹279 cr-0.64
DSP Large & Mid Cap FundLarge & Mid CapC1.27%₹277 cr-0.33
HDFC Large & Mid Cap FundLarge & Mid CapB0.95%₹267 cr–
Nippon India Pharma FundSectoral/ThematicC2.90%₹264 cr+0.03
UTI - Flexi Cap Fund.Flexi CapB1.11%₹249 cr–
Nippon India Multi Cap FundMulti CapB0.45%₹236 cr+0.01
DSP ELSS Tax Saver FundELSSB1.41%₹220 cr-0.02
PGIM India Midcap FundMid CapB1.97%₹202 cr+1.00
Franklin India Mid Cap FundMid CapC1.55%₹180 cr–
Axis Flexi Cap FundFlexi CapB1.21%₹159 cr–
Quant Mid Cap FundMid CapB2.01%₹151 cr–
UTI - Mid Cap FundMid CapC1.16%₹134 cr–
Mirae Asset Healthcare FundSectoral/ThematicA3.33%₹119 cr-0.06
HDFC Multi Cap FundMulti CapC0.59%₹113 cr–
HDFC Pharma and Healthcare FundSectoral/ThematicA+2.98%₹109 cr–
Edelweiss Small Cap FundSmall CapB1.57%₹105 cr–
WhiteOak Capital Mid Cap FundMid CapB1.33%₹103 cr–
Kotak Contra FundValue / ContraB1.68%₹85 cr–
Nippon India Balanced Advantage FundBalanced AdvantageA0.76%₹72 cr–
Edelweiss Large & Mid Cap FundLarge & Mid CapB1.31%₹60 cr–
Tata Ethical FundSectoral/ThematicC1.54%₹57 cr–
Baroda BNP Paribas Mid Cap FundMid CapB2.28%₹56 cr+0.05
Aditya Birla Sun Life Midcap FundMid CapC0.85%₹53 cr–
DSP Flexi Cap FundFlexi CapB0.45%₹52 cr+0.00
Axis India Manufacturing FundSectoral/Thematic–0.96%₹52 cr–
Nippon India Vision Large & Mid Cap FundLarge & Mid CapC0.66%₹48 cr+0.01
DSP Multi Cap FundMulti Cap–1.72%₹48 cr+0.05
DSP Focused FundFocusedB1.78%₹44 cr-0.19
UTI - Healthcare FundSectoral/ThematicB2.81%₹40 cr–
DSP Aggressive Hybrid FundAggressive HybridA0.32%₹36 cr–
Edelweiss Flexi Cap FundFlexi CapB0.97%₹34 cr–
Aditya Birla Sun Life Pharma and Healthcare FundSectoral/ThematicC2.71%₹29 cr–

And 55 more schemes with smaller holdings.

Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.

Common questions

How many mutual funds hold IPCA Laboratories shares?

95 schemes held IPCA Laboratories in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹13,288 cr in all.

Which mutual fund holds the most IPCA Laboratories shares?

By value, HDFC Mid Cap Fund: about ₹3,453 cr, 3.43% of the fund.

Where does this data come from?

From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.

This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.

Free portfolio review

Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.

Chat with us